Summary
We report on a 67-year-old man with Felty's syndrome (FS) complicated by recurrent pneumonia and an infected wound, which was not healing in spite of maximal antibiotic and local therapy. Encouraged by previous experience, we treated him with granulocyte-macrophage colony-stimulating factor (GM-CSF). His total leukocyte count rose, but the patient's pneumonia deteriorated. In addition, a previously known chronic obstructive lung disease (COLD) was exacerbated acutely. These complications finally led to his death. Postmortem examination revealed widespread pneumonia with invasive aspergillosis and a peripheral adenocarcinoma in his left lung.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Addison IE, Johnson B, Deverreux S, et al. (1989) GM-CSF may inhibit neutrophil migration in vivo. Clin Exp Immunol 76: 149–153
Antman KH (1990) G-CSF and GM-CSF in clinical trials. Yale J Biol Med 63: 387–410
Arning M, Klicle KO, Schneider W (1991) GM-CSF therapy and capillary leak syndrome. Ann Hemat 62: 83
Baldwin GC, Gasson JC, Kaufmann SE, et al. (1989) Non-hematopoietic tumor cells express functional M-CSF receptors. Blood 73: 1033
Biesma B, Varies EGE de, Willemse PHB, et al. (1990) Efficacy and tolerability of recombinant human GM-CSF in patients with chemotherapy-related leukopenia and fever. Eur J Cancer 26: 932–936
Cebon JS, Morstyn G (1990) The potential role of GM-CSF in cancer chemotherapy. Cancer Surv 9: 131–155
Champlin RE, Nimer SD, Ireland P, et al. (1989) Treatment of refractory aplastic anemia with recombinant human GM-CSF. Blood 73: 694–699
Emminger W, Emminger-Schmidmeier W, Peters C, et al. (1990) Capillary leak syndrome during low-dose GM-CSF treatment of a patient in a continuous febrile state. Blut 61: 219–221
Golde DW (1990) Overview of myeloid growth factors. Semin Hematol 27 [Suppl 3]: 1–7
Hazenberg BPC, Van Leeuwen MA, Van Rijswijk MH, et al. (1989) Correction of granulocytopenia in Felty's syndrome by GM-CSF. Simultaneous induction of interleukin-6 release and flare up of the rheumatoid arthritis. Blood 74: 2769–2773
Hoffken K, Overkamp F, Stirbu J, et al. (1990) recombinant human GM-CSF and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase-II study Onkologie 13: 33–37
Joseph G, Neustadt DH, Hamm J, et al. (1991) GM-CSF in the treatment of Felty's syndrome. Am J Hematol 37: 55–56
Kaczmarski RS, Mufti GJ (1990) Hypoalbuminaemia after prolonged treatment with recombinant granulocyte-macrophage colony-stimulating factor. Br Med J 301: 1312–1313
Lieschke G, Cebon J, Morstyn G (1989) Characterization of the clinical effects after the first dose of GM-CSF. Blood 74: 2634–2643
Lubbe AS, Schwella N, Riess H, et al. (1990) Improvement of pneumonia and arthritis in Felty's syndrome by treatment with GM-CSF. Blut 61: 379–380
Markusse HM, Breedveld FC, Fibbe WE, et al. (1990) GM-CSF treatment of neutropenia associated with Felty's syndrome. Arthritis Rheum 3: 1865–1867
Nemunaitis J, Rabinowe S, Singer J, et al. (1991) Recombinant GM-CSF after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324: 1773–1778
Philips N, Jacobs S, Stoller R, et al. (1989) Effect of recombinant human GM-CSF on myelopoiesis in patient with refractory metastatic carcinoma. Blood 74: 26–34
Powles R, Smith C, Milan S, et al. (1990) Human recombinant GM-CSF in allogenic bone marrow transplantation for leukaemia: double-blind placebo-controlled trial. Lancet 336: 1417–1420
Robinson BE, Quesenberry PJ (1990) Hemopoietic growth factors: overview and clinical applications, part I. Am J Med Sci 300: 163–170
Robinson BE, Quesenberry PJ (1990) Hemopoietic growth factors: overview and clinical applications, part II. Am J Med Sci 300: 237–244
Robinson BE, Quesenberry PJ (1990) Hemopoietic growth factors: overview and clinical applications, part III. Am J Med Sci 300: 311–321
Sisson SD, Dinarello CA (1988) Production of interleukin-1B and tumor necrosis factor by human mononuclear cells stimulated with GM-CSF. Blood 72: 1368–1374
Steward WP, Scarfee JH, Austin R, et al. (1989) recombinant human GM-CSF given as daily short infusions. A phase-I dose-toxicity study. Br J Cancer 59: 142–145
Steward WP, Thatcher N, Kaye SB (1990) Clinical applications of myeloid colony-stimulating factors. Cancer Treat Rev 17: 77–78
Thomassen MJ, Muzaffar A, Barna BP, et al. (1991) Induction of cytokine in RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving GM-CSF therapy. Cancer Res 51: 857–862
Thompson JA, Lee DJ, Kidd P, et al. (1989) Subcutanous GM-CSF in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects. J Clin Oncol 7: 629–637
Varies EGE de, Biesma B, Willemse PHB, et al. (1991) A double-blind chemotherapy for ovarian carcinoma. Cancer Res 51: 116–122
Verhoef G, Boogaerts M (1991) Treatment with GM-CSF and adult respiratory distress syndrome. Am J Hematol 36: 285–287
Weisbart RH, Gasson JC, Golde DW (1989) Colony-stimulating factors and host defence. Ann Intern Med 110: 297–303
Wing EJ, Mitchell-Magee D, Whiteside TL, et al. (1989) Recombinant human GM-CSF enhances monocyte cytotoxicity and secretion of human necrosis factor-a and interferon in cancer patients. Blood 73: 643–646
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gari-Bai, A.R., Rochlitz, C., Riewald, M. et al. Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor — hematological response accompanied by pulmonary complications with lethal outcome. Ann Hematol 65, 232–235 (1992). https://doi.org/10.1007/BF01703951
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01703951